376 related articles for article (PubMed ID: 25632961)
21. Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.
Frias MA; Mukhopadhyay S; Lehman E; Walasek A; Utter M; Menon D; Foster DA
J Biol Chem; 2020 Jan; 295(1):263-274. PubMed ID: 31767684
[TBL] [Abstract][Full Text] [Related]
22. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
23. Reduced mortality and moderate alcohol consumption: the phospholipase D-mTOR connection.
Foster DA
Cell Cycle; 2010 Apr; 9(7):1291-4. PubMed ID: 20372065
[TBL] [Abstract][Full Text] [Related]
24. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation.
Lee YK; Lee WS; Kim GS; Park OJ
Oncol Rep; 2010 Dec; 24(6):1471-7. PubMed ID: 21042741
[TBL] [Abstract][Full Text] [Related]
25. A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells.
Fite K; Elkhadragy L; Gomez-Cambronero J
Mol Cell Biol; 2016 Jan; 36(7):1078-89. PubMed ID: 26787840
[TBL] [Abstract][Full Text] [Related]
26. A systems study reveals concurrent activation of AMPK and mTOR by amino acids.
Dalle Pezze P; Ruf S; Sonntag AG; Langelaar-Makkinje M; Hall P; Heberle AM; Razquin Navas P; van Eunen K; Tölle RC; Schwarz JJ; Wiese H; Warscheid B; Deitersen J; Stork B; Fäßler E; Schäuble S; Hahn U; Horvatovich P; Shanley DP; Thedieck K
Nat Commun; 2016 Nov; 7():13254. PubMed ID: 27869123
[TBL] [Abstract][Full Text] [Related]
27. Phospholipase D1 mediates AMP-activated protein kinase signaling for glucose uptake.
Kim JH; Park JM; Yea K; Kim HW; Suh PG; Ryu SH
PLoS One; 2010 Mar; 5(3):e9600. PubMed ID: 20231899
[TBL] [Abstract][Full Text] [Related]
28. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
29. Phospholipase D and mTORC1: nutrients are what bring them together.
Wiczer BM; Thomas G
Sci Signal; 2012 Mar; 5(217):pe13. PubMed ID: 22457329
[TBL] [Abstract][Full Text] [Related]
30. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
31. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR
Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071
[TBL] [Abstract][Full Text] [Related]
32. Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid.
Yoon MS; Rosenberger CL; Wu C; Truong N; Sweedler JV; Chen J
Mol Cell; 2015 May; 58(3):549-56. PubMed ID: 25936805
[TBL] [Abstract][Full Text] [Related]
33. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells.
Appuhamy JA; Nayananjalie WA; England EM; Gerrard DE; Akers RM; Hanigan MD
J Dairy Sci; 2014; 97(1):419-29. PubMed ID: 24183687
[TBL] [Abstract][Full Text] [Related]
34. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
[TBL] [Abstract][Full Text] [Related]
35. 1,25-Dihydroxyvitamin D
Kim Y; Kim HS; Sohn J; Ji JD
Biochem Biophys Res Commun; 2019 Nov; 519(4):909-915. PubMed ID: 31563324
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.
Yoon MS; Sun Y; Arauz E; Jiang Y; Chen J
J Biol Chem; 2011 Aug; 286(34):29568-74. PubMed ID: 21737445
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase D-mediated autophagic regulation is a potential target for cancer therapy.
Jang YH; Choi KY; Min DS
Cell Death Differ; 2014 Apr; 21(4):533-46. PubMed ID: 24317201
[TBL] [Abstract][Full Text] [Related]
38. Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis through inhibition of mTORC1 signaling.
Burgos SA; Kim JJ; Dai M; Cant JP
Horm Metab Res; 2013 Mar; 45(3):183-9. PubMed ID: 22972179
[TBL] [Abstract][Full Text] [Related]
39. The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy.
You JS; Lincoln HC; Kim CR; Frey JW; Goodman CA; Zhong XP; Hornberger TA
J Biol Chem; 2014 Jan; 289(3):1551-63. PubMed ID: 24302719
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of kinase IP6K1 and repression of myo-inositol-3-P synthase.
Lazcano P; Schmidtke MW; Onu CJ; Greenberg ML
J Biol Chem; 2022 Sep; 298(9):102363. PubMed ID: 35963434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
